Dossier
Tom Engels
Coverage of Tom Engels in the Nexus archive.
- STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
The Trump administration revised a pilot for the 340B Drug Pricing Program, allowing pharmaceutical companies to offer rebates instead of upfront discounts. The change, effective Jan. 1, 2027, targets drugs and companies involved in Medicare Drug Price Negotiation Program rounds, angering hospitals and clinics.